NCT02389972View on ClinicalTrials.gov

Effectiveness of Dasatinib in Adult Patients With Chronic Myeloid Leukemia in China: A Multicenter, Registry Study

CompletedOBSERVATIONAL
Enrollment

128

Participants

Timeline

Start Date

April 11, 2013

Primary Completion Date

July 13, 2017

Study Completion Date

July 13, 2017

Conditions
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Interventions
DRUG

Dasatinib

Trial Locations (1)

430022

Local Institution, Wuhan

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY